ADVERTISEMENT
Search

 

Press Releases

 

30

Sep

2022

APhA Statement on Monkeypox PREP Act Declaration

Author: James Keagy

(WASHINGTON, DC) Ilisa Bernstein, PharmD, JD, FAPhA, interim executive vice president and CEO of the American Pharmacists Association (APhA) released the following statement regarding HHS Secretary Becerra signing a Public Readiness and Emergency Preparedness (PREP) Act declaration that grants pharmacists the authority to administer monkeypox vaccines.  

Comments (0)
Number of views (4955)
Article rating: No rating

9

Sep

2022

AMA, APhA, ASHP, NCPA Statement on State Laws Impacting Patient Access to Medically Necessary Medications

Author: James Keagy

WASHINGTON, DC—The American Medical Association (AMA), American Pharmacists Association (APhA), American Society of Health-System Pharmacists (ASHP), and National Community Pharmacists Association (NCPA) are concerned about state laws that limit patients’ access to medically necessary medications and impede physicians and pharmacists from using their professional judgment.

Comments (0)
Number of views (5715)
Article rating: No rating

13

Jul

2022

New Federal Guidance confuses an already complicated landscape for pharmacists

Author: James Keagy

Today, in response to the U.S. Supreme Court recent decision in Dobbs v Jackson Women’s Health Organization, the U.S. Department of Health and Human Services’ Office for Civil Rights (OCR) released guidance for pharmacies that sets forth their obligations under federal civil rights laws, conflicting with some state laws, and raises concerns for our nation's pharmacies and pharmacists.

Comments (0)
Number of views (8394)
Article rating: No rating

6

Jul

2022

Breaking: FDA permits pharmacists to prescribe Paxlovid to treat COVID-19

Author: James Keagy

Today, after months of effort by APhA and other stakeholders, FDA has updated the EUA for the COVID-19 oral antiviral, Paxlovid, to permit pharmacists to order and prescribe Paxlovid under certain conditions.

Comments (0)
Number of views (14985)
Article rating: No rating

2

Jun

2022

APhA Changes Executive Leadership

Ilisa Bernstein appointed Interim CEO

The Board of Trustees of the American Pharmacists Association announced today that Ilisa Bernstein, PharmD, JD, FAPhA, has been named Interim CEO, effective immediately. Bernstein’s appointment follows the departure of Scott Knoer, PharmD, MS, as Executive Vice-President and CEO.

Comments (0)
Number of views (17444)
Article rating: No rating
RSS
First1011121314161819
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT